Skip to main content
. 2018 Feb 6;9(2):74. doi: 10.3390/genes9020074

Figure 4.

Figure 4

(A) Synthetic strategy for the preparation of SQ-siRNA NPs. (B) MTT assay at several concentrations of SQ-siRNA NPs and incubation times. (C) Reduction of RET/PTC1 mRNA expression in vitro after incubating siRNA RET/PTC1 (60 nM) in the presence of lipofectamine. (D) Effect of SQ-siRNA NPs in reducing the tumour growth after 20 days of treatment. (E) Reduction of RET/PTC21 mRNA expression measured by qRT-PCR after incubation with SQ-siRNA NPs in vivo. The silence activity mediated by SQ-siRNA NPs was significant (*) when compared to untreated cells according to ANOVA analysis. A scrambled siRNA sequence (control siRNA) was used in order to determine the specificity of the gene silencing process. Adapted with permission from ref. [118]. Copyright 2011, American Chemical Society.